“However, there is no scientific evidence that feeling bad is caused by any form of “chemical imbalance” in the brain. The hypothesis has been rejected in the following sententious way by one of the most renowned persons in the area of psychopharmacology: ”The serotonin theory of depression is comparable to the masturbatory theory of insanity.””
Wow, what a great quote! I have taken several excerpts from the following article and listed them below: http://jannel.se/suicide.psychiatricdrugs.pdf
Please read the entire article for more information on the number of drugs given to the victims.
Here is the press release from the author:
New data shows antidepressants and neuroleptics involved in 77 percent of reported suicides
A unique new report gives detailed data about suicides and psychiatric drugs.
Stockholm Sweden 8-08-2008 03:37 GMT (TransWorldNews)
In the marketing material of antidepressants and neuroleptics it is claimed that the drugs “correct a chemical imbalance in the brain“, are “adjusting the imbalance of chemicals”. It is claimed that these drugs protect against suicide.
The data in this report shows the opposite:
In the group studied the men and women, in an overwhelming high degree, had committed suicide after having been treated with large amounts of psychiatric drugs in the year before and at the time of their suicide.
Read the full report on http://jannel.se/suicide.psychiatricdrugs.pdf
Reporter – investigating psychiatry
And here are some excerpts from the actual article:
Suicides & Psychiatric Drugs
This is a unique report about suicides and psychiatric drugs.
It gives detailed data about the treatment preceding death for around one third of all persons who committed suicide in Sweden in 2007.
This data could have or should have been published by the responsible agency, the National Board of Health and Welfare. It was not. The facts presented here were gathered directly from data existing in the files and registries of the Board.
The breakdown of the reporting system
In 86% of the cases of suicide reported to the National Board of Health and Welfare for 2007 – that is in 338 of 393 cases – the persons were treated with psychiatric drugs.
In 0% (!) of these cases the matter was reported as a drug adverse event to the registry for drug adverse events at the Medical Products Agency (MPA).
In not a single one of all these cases of suicide did the responsible doctor (in most cases psychiatrists) consider that the tragic result could have been caused by the psychiatric drug or that the drug was a suspected contributory factor for the fatal result.
If not even fatal results in the form of suicides following extensive treatment with psychiatric drugs are reported to the registry for adverse drug events, how should it then be with all other harmful effects patients are subjected to?
The ”adequate drug treatment”
“…old myths about the protective effect of antidepressants and neuroleptics against suicide – directly taken from the false marketing material of the pharmaceutical companies – still govern the activities at the top of the National Board of Health and Welfare.”
In the investigations about these suicides done by the National Board of Health and Welfare one thing is consistently lacking: The question if the content of the psychiatric treatment could have caused or contributed to the tragic end result – suicide. And the content was in 86% of the cases psychiatric drugs.
Instead of challenging the role of the psychiatric drugs, the reporting psychiatrists and the doctors at the National Board of Health and Welfare agree – as evidenced in the investigation material and in the complete lack of reports to the registry for adverse drug events – that the persons committing suicide got “adequate drug treatment”.
The officials at the National Board of Health and Welfare know that the psychiatric drugs can induce suicidality or increased suicidality (especially in the beginning, when doses are increased/lowered, when other drugs are added, or during the withdrawal phase). They are aware about the now accepted serious harmful drug effect akathisia as an underlying cause in cases of suicide and violence against others. They know that serious physical and mental conditions can be caused by the use of several psychiatric drugs at the same time and, as written before, the “adequate drug treatment” among the persons committing suicide was on the average four different psychiatric drugs the preceding year. There is in the material submitted to the Board about the treatment an abundance of evidence that harmful effects induced by the drugs are seen as even more “symptoms” – and that these harmful effects are then handled with even more drugs, with a fatal outcome.
But the psychiatric drugs are not challenged. No questions are asked about their role in the subsequent suicides. And the very reason for this is that old myths about the protective effect of antidepressants and neuroleptics against suicide – directly taken from the false marketing material of the pharmaceutical companies – still govern the activities at the top of the National Board of Health and Welfare.
Considering the results presented in this report it is no longer possible to say that ”more” of the same sort is the solution to the problem. It’s not “more psychiatry” – more psychiatric drugs – that is the solution.
Politicians, trying to surpass each other in demanding more funds for a psychiatric industry that only means more “treatment” with psychiatric drugs should know that they directly contribute to harming people and to the creation of more “results” of the sort presented in this report.
Subservient nodding and voting when psychiatric opinion leaders require changes in law so that people can be drugged with force in their homes, and so that “drug treatment without exceptions” can be given for people with mental problems only lead to an increase in the psychiatric results described earlier.
This report clearly shows one thing: Almost all persons committed suicide after having had “adequate drug treatment” – in the meaning used in psychiatry; the very treatment that should prevent suicide.
There is no reason to believe that the reporting system for adverse drug effects work better in other countries. The catastrophic state of these “surveillance systems” makes it possible to keep destructive drugs on the market year after year. All it takes is for pharmaceutical companies to show that many persons have been exposed to these drugs, and that almost no adverse event reports have been submitted, so the drugs must be “safe and effective”.
This example from Sweden shows that in 338 cases persons committed suicide after having been prescribed psychiatric drugs – and none of these cases were reported to the registry for adverse drug events. Instead of Eli Lilly claiming that the drug Zyprexa was involved in 0 cases of suicide in Sweden 2007, the fact was that the drug was involved in 52 cases in this group of 338 persons. Instead of Wyeth claiming the same for Effexor, the fact was that the drug was involved in 41 cases in this group.
The reporting system must be completely reformed right away. It must be made mandatory for health care professionals to directly report all suspected serious adverse drug effects, and persons not reporting must be disciplined. Patients must be fully informed about the actual harmful effects of the drugs and given the right to report these effects to the adverse events registry with the promise of effective follow-up. The reformed system must not give room for the now ruling psychiatric concealment ideology, where obvious harmful effects of psychiatric drugs are treated as “symptoms” requiring more drugs. Instead all these effects must be reported as suspected harmful effects by the drugs.
And, most importantly, the data presented in this report must lead to basic changes in the ways in which persons with mental problems are being cared for.